Clorox Co. Stock (US1890541097): Valuation metrics in focus after recent rebound
12.06.2026 - 09:46:42 | ad-hoc-news.deResponsible: ad hoc news Markets & Valuation Desk. Reviewed prior to publication on June 11, 2026 at 4:26 PM ET. Details in the imprint.
Clorox Co. is back on the radar of U.S. retail investors as the stock trades closer to $100 after a volatile two-year stretch marked by pandemic demand swings, cost inflation and a cybersecurity incident. On June 10, 2026, Clorox shares closed around $99.90 on the New York Stock Exchange, up roughly 1.4 percent on the day, according to finanzen.net data referencing the U.S.-dollar listing. With the stock no longer near its 52-week lows yet still well below its pre-pandemic peaks above $200, the current setup is increasingly a valuation story for the consumer staples name.
Clorox valuation under the microscope after earnings reset
Clorox is part of the U.S. consumer staples universe and competes with giants like Procter & Gamble, Colgate-Palmolive and Reckitt in categories such as cleaning, laundry additives and household products. The company makes well-known brands including Clorox bleach, Pine-Sol, Kingsford charcoal, Glad trash bags (through a joint venture) and Hidden Valley, which give it broad shelf presence in U.S. grocery and mass retail channels. As a defensive stock in a traditionally lower-volatility sector, Clorox has often traded at a premium valuation versus the broader U.S. equity market and sometimes versus peers.
Recent earnings reports have reshaped that valuation discussion. For its most recently reported quarter, Clorox posted net sales that grew at a mid-single-digit percentage rate year over year as pricing actions and improved supply offset softer volumes in some categories, according to the company’s investor materials. Management highlighted that gross margin expanded compared with the prior-year period, reflecting lower commodity costs, improved manufacturing productivity and the anniversary of higher logistics expenses. Operating income and earnings per share also improved versus the prior-year quarter, although from a depressed base tied to elevated costs and the earlier cyberattack disruption.
On a trailing basis, these results translate into a price-to-earnings ratio in the mid-20s, based on recent market capitalization near $12 billion and consensus earnings estimates for the current fiscal year referenced by sell-side data providers. That puts Clorox at a premium to the broader S&P 500 on some metrics but more in line with consumer staples peers that command higher multiples due to their brand strength and cash flow visibility. Some analysts have noted that Clorox’s multiple remains elevated relative to its recent earnings growth rate, which has been constrained by cost pressures and volume headwinds in certain categories.
Cash generation is a key part of the valuation discussion. Clorox has historically converted a high percentage of its net income into operating cash flow, which has supported both dividends and share repurchases in prior years. Following the cyberattack and cost inflation shock, free cash flow metrics temporarily weakened but showed signs of improvement in the latest quarters as margins recovered and working capital normalized. The company has reiterated its focus on disciplined capital allocation, with priorities including reinvestment in the business, maintaining an investment-grade balance sheet and returning cash to shareholders primarily via dividends.
The dividend is central to how many U.S. income-focused investors view Clorox. The company is recognized as a long-standing dividend payer and is often cited among dividend growth names due to its history of annual increases. At the recent share price near $100, Clorox’s forward dividend yield screens higher than the yield on the S&P 500 index and competes with many other consumer staples payers, though below some higher-yielding utilities and telecom stocks. The combination of a relatively high payout ratio and the need to fund operational investments has prompted some analysts to argue that future dividend growth may track earnings growth more closely than in the past.
Balance sheet metrics also feed into valuation. Clorox carries a meaningful amount of debt relative to its equity value, in part due to prior acquisitions and shareholder return programs, but management has emphasized deleveraging over time. Credit rating agencies currently rate Clorox in the investment-grade category, reflecting stable cash flows from its household brands and its leading market positions across several segments. Interest expense has risen with higher rates, but the company has used cash flow to manage maturities and maintain liquidity, a factor that supports equity valuation by limiting refinancing risk.
From a market perspective, Clorox sits within the S&P 500 consumer staples cohort and therefore features in many passive index and sector ETF allocations. The stock’s beta has historically been below 1, consistent with its defensive profile and stable end demand for cleaning and household products. However, the last few years have shown that even staples can see significant share price volatility when margins come under pressure or when operational disruptions hit. The normalization of margins and the stabilization of volumes are therefore closely watched as the market weighs whether the current valuation multiple is sustainable.
Overall, the Clorox stock story at current levels revolves less around dramatic growth and more around the durability of cash flows, the pace of margin recovery and the resilience of its dividend program. For investors watching the stock, key signposts will likely include management’s updates on pricing versus volume, progress on productivity initiatives and any changes in capital allocation priorities when the company provides future quarterly results.
Clorox Co. at a glance
- Name: Clorox Co.
- Industry: Household and personal products
- Headquarters: Oakland, California, United States
- Core markets: United States, selected international markets
- Revenue drivers: Cleaning and disinfecting products, household and lifestyle brands, professional solutions
- Listing: NYSE, ticker symbol CLX; member of the S&P 500 index
- Trading currency: US dollar (USD)
More insights on the Clorox Co. stock
Stay on top of further earnings updates, valuation angles and sector moves related to Clorox Co. on ad hoc news.
More Clorox Co. news Investor RelationsThis article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.
